Dr. Tyson Kim, MD, PhD

Dr. Kim practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kim's NPI, 1568881555, was assigned on April 8, 2014. Dr. Kim graduated from University of California, San Francisco School of Medicine in 2014. Dr. Kim's California license number on file is 164743.

Dr. Kim's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kim's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kim to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 5 sites in all. Vendor and product names are available with a free account.

Cornea and external diseases specialist is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207WX0120X. Dr. Kim is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kim's licenses on file in 4 states: California, Florida, Michigan and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eye infection or inflammation, glaucoma, hereditary corneal conditions and secondary membranaous cataract surgery among the conditions Dr. Kim treats.

CMS data shows 541 Medicare services from Dr. Kim across 6 procedure codes in 2024, for 136 Medicare patients. Medicare paid $32,696 for them.

CMS counts 136 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 52 patients. 70% of them have high blood pressure, and 61% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 74, with 58% women.

In 2024, Dr. Kim wrote 227 Medicare Part D claims for 44 patients. 44% of them were for generic drugs. CMS names the drug for 165 of them, across 5 drugs with 11 or more claims each, at $5,450 in total drug cost. In 2023, CMS named 79 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth. CMS counts 74 procedures of cataract surgery by Dr. Kim, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Kim, published from 2008 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Receptors, Notch, Signal Transduction and Endothelial Cells. Dr. Kim has published most often in JAMA Ophthalmol. Dr. Kim's most frequent co-authors are Todd Paul Margolis, MD, Vaidehi Shradha Dedania, MD and Philip Lieu, MD.

CMS Open Payments shows 22 general payments to Dr. Kim from 10 drug and device companies from 2018 to 2025. Grants make up the largest share, 98% of the total. Alcon Research Ltd paid the most, $90,000.

Dr. Kim graduated from University of California, San Francisco School of Medicine in 2014.

Dr. Kim is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.